We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+0.6%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$768M
AUM Growth
+$145M
(+23%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-49.45%
Top 10 Holdings %
Top 10 Hldgs %
72.07%
Holding
132
New
51
Increased
25
Reduced
6
Closed
37
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$14.4M |
| 2 |
Vistra Energy Corp.
DYNC
|
+$4.34M |
| 3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
+$1.78M |
| 4 |
Insmed
INSM
|
+$1.65M |
| 5 |
Allied World Assurance Co Hld Lt
AWH
|
+$823K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACOR
Acorda Therapeutics
ACOR
|
+$5.92M |
| 2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
+$4.78M |
| 3 |
Micron Technology
MU
|
+$4.25M |
| 4 |
BEAV
B/E Aerospace Inc
BEAV
|
+$898K |
| 5 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$657K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 95.68% |
| 2 | Technology | 2.11% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.33% |
| 5 | Consumer Staples | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
PUT
Arista Networks
ANET
$232B
| $28.4M | 3.7% |
+3,032,000
| New | +$27.5M |
2017 Q2
0 quarters
|
|
2
CALL
DELISTED
Sage Therapeutics
SAGE
| $24.4M | 3.18% |
307,000
+61,200
| +25% | +$4.42M |
2017 Q1
1 quarter
|
|
|
SIOX
3
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $18.7M | 2.44% |
100,950
+35,112
| +53% | +$6.15M |
2017 Q1
1 quarter
|
|
|
4
Arista Networks
ANET
$232B
| $14.9M | 1.94% |
+1,588,832
| New | +$14.4M |
2017 Q2
0 quarters
|
|
5
PUT
NXP Semiconductors
NXPI
$57.5B
| $13.2M | 1.72% |
+120,600
| New | +$12.9M |
2017 Q2
0 quarters
|
|
|
ZYNE
6
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $8.25M | 1.07% |
485,900
+337,500
| +227% | +$6.71M |
2017 Q1
1 quarter
|
|
7
CALL
DBV Technologies S.A. American Depositary Shares
DBVT
$569M
| $8.23M | 1.07% |
23,030
+10,420
| +83% | +$3.56M |
2017 Q1
1 quarter
|
|
8
PUT
Intel
INTC
$498B
| $6.75M | 0.88% |
+200,000
| New | +$7.16M |
2017 Q2
0 quarters
|
|
|
ZYNE
9
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $6.19M | 0.81% |
364,300
+261,900
| +256% | +$5.21M |
2017 Q1
1 quarter
|
|
10
PUT
ANI Pharmaceuticals
ANIP
$1.67B
| $6.08M | 0.79% |
130,000
-46,000
| -26% | -$2.22M |
2016 Q4
2 quarters
|
|
|
11
CALL
NXP Semiconductors
NXPI
$57.5B
| $5.8M | 0.75% |
53,000
-125,400
| -70% | -$13.4M |
2017 Q1
1 quarter
|
|
|
OTIC
12
CALL
DELISTED
Otonomy, Inc.
OTIC
| $5.79M | 0.75% |
+307,500
| New | +$4.29M |
2017 Q2
0 quarters
|
|
|
13
PUT
Insmed
INSM
$21.5B
| $5.06M | 0.66% |
295,000
-35,400
| -11% | -$605K |
2017 Q1
1 quarter
|
|
|
14
DELISTED
Vistra Energy Corp.
DYNC
| $4.58M | 0.6% |
+75,000
| New | +$4.34M |
2017 Q2
0 quarters
|
|
15
PUT
Howmet Aerospace
HWM
$86.9B
| $4.53M | 0.59% |
+260,800
| New | +$5.31M |
2017 Q2
0 quarters
|
|
|
MNK
16
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.48M | 0.58% |
+100,000
| New | +$4.39M |
2017 Q2
0 quarters
|
|
|
IMMU
17
CALL
DELISTED
Immunomedics Inc
IMMU
| $4.08M | 0.53% |
461,200
+354,000
| +330% | +$2.49M |
2017 Q1
1 quarter
|
|
|
TTPH
18
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $4.06M | 0.53% |
+28,500
| New | +$4.4M |
2017 Q2
0 quarters
|
|
|
IMMU
19
PUT
DELISTED
Immunomedics Inc
IMMU
| $3.95M | 0.51% |
+447,200
| New | +$3.14M |
2017 Q2
0 quarters
|
|
20
PUT
Tvardi Therapeutics
TVRD
$14M
| $3.46M | 0.45% |
+6,250
| New | +$3.97M |
2017 Q2
0 quarters
|
|
|
ARAV
21
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
| $3.03M | 0.39% |
28,983
+10,750
| +59% | +$1.15M |
2017 Q1
1 quarter
|
|
22
PUT
DELISTED
Vector Group Ltd.
VGR
| $2.98M | 0.39% |
228,515
+197,502
| +637% | +$2.6M |
2016 Q4
2 quarters
|
|
|
ZGNX
23
PUT
DELISTED
Zogenix, Inc.
ZGNX
| $2.92M | 0.38% |
+201,500
| New | +$2.53M |
2017 Q2
0 quarters
|
|
24
CALL
Palisade Bio
PALI
$265M
| $2.1M | 0.27% |
+4
| New | +$1.75M |
2017 Q2
0 quarters
|
|
|
25
Insmed
INSM
$21.5B
| $1.66M | 0.22% |
+96,730
| New | +$1.65M |
2017 Q2
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, DLD Asset Management held 132 positions worth $768M, up 23% from $623M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
DLD Asset Management withdrew a net $380M in Q2 2017, closing 37 positions and reducing 6 holdings. Its most notable exit was Acorda Therapeutics, an estimated $5.92M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 96% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DLD Asset Management opened a new position in Arista Networks worth $14.9M.
- DLD Asset Management's largest Q2 2017 buy was Arista Networks: 1,588,832 shares worth $14.9M.
- DLD Asset Management added most to Level 3 Communications Inc in Q2 2017, an estimated $759K increase.
- DLD Asset Management fully exited Acorda Therapeutics in Q2 2017, selling an estimated $5.92M.
- DLD Asset Management's ten largest holdings make up 72% of its $768M portfolio in Q2 2017.
- DLD Asset Management opened 51 new positions and closed 37 in Q2 2017.
- DLD Asset Management's portfolio value rose 23% quarter-over-quarter to $768M.
Based on DLD Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.